Research Propelling Cancer Prevention and Cures
The AACR Annual Meeting highlights the best cancer science and medicine from institutions all over the world. Attendees are invited to stretch their boundaries, form collaborations, attend sessions outside their own areas of expertise, and learn how to apply exciting new concepts, tools, and techniques to their own research.
Cynvenio's Dr. Paul Dempsey will discuss how the LiquidBiopsy™ Platform was used in a breast cancer research study to evaluate epithelial tumor cells and tumor cells in epithelial mesenchymal transition (EMT) from circulating tumor cells (CTCs), cell-free DNA (cfDNA) and solid tissue samples.
See the LiquidBiopsy platform at the Thermo Fisher Scientific booth (#1501).